Treatment of Schamberg's disease with pentoxifylline--therapeutic trial.

Abstract

Twenty patients with Schamberg's disease were started on pentoxifylline (400 mg once daily) for a period of 8 weeks. Improvement was assessed at 2 weekly intervals by two observers independently and graded as mild (< 25%, moderate (25-50%) and marked (>50%). Marked improvement was observed in 10/20(50%) patients. We conclude that pentoxifylline should be considered as first line therapy in all patients with Schamberg's disease.

• Authors: V Gandhi, A Singal, B Sachdeva, S N Bhattacharya
• Journal: Indian journal of dermatology, venereology and leprology (Indian J Dermatol Venereol Leprol) 2003 Jan-Feb Vol. 69 Issue 1 Pg. 25-6 ISSN: 0973-3922 [Electronic] United States
• PMID: 17642818 (Publication Type: Journal Article)